PortfoliosLab logoPortfoliosLab logo
IMOS vs. VMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IMOS vs. VMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ChipMOS TECHNOLOGIES INC. (IMOS) and Viemed Healthcare Inc (VMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IMOS achieves a 159.12% return, which is significantly higher than VMD's 65.68% return.


IMOS

1D
1.90%
1M
23.93%
6M
109.77%
YTD
159.12%
1Y
319.32%
3Y*
55.23%
5Y*
23.07%
10Y*
21.60%

VMD

1D
0.41%
1M
17.80%
6M
70.03%
YTD
65.68%
1Y
82.64%
3Y*
10.19%
5Y*
11.57%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IMOS vs. VMD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
IMOS
ChipMOS TECHNOLOGIES INC.
159.12%64.28%-27.86%34.76%-32.61%49.82%12.33%38.76%-4.97%
VMD
Viemed Healthcare Inc
65.68%-7.36%2.17%3.84%44.83%-32.73%25.16%63.16%122.18%

Correlation

The correlation between IMOS and VMD is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2018

0.12

Fundamentals

Market Cap

IMOS:

$2.65B

VMD:

$471.93M

EPS

IMOS:

NT$9.58

VMD:

$0.37

PE Ratio

IMOS:

253.69

VMD:

33.38

PS Ratio

IMOS:

4.57

VMD:

1.73

PB Ratio

IMOS:

3.47

VMD:

3.46

Total Revenue (TTM)

IMOS:

NT$18.75B

VMD:

$286.57M

Gross Profit (TTM)

IMOS:

NT$2.12B

VMD:

$163.52M

EBITDA (TTM)

IMOS:

-NT$130.72M

VMD:

$46.09M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IMOS vs. VMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMOS
IMOS Risk / Return Rank: 9898
Overall Rank
IMOS Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
IMOS Sortino Ratio Rank: 9797
Sortino Ratio Rank
IMOS Omega Ratio Rank: 9595
Omega Ratio Rank
IMOS Calmar Ratio Rank: 9999
Calmar Ratio Rank
IMOS Martin Ratio Rank: 9898
Martin Ratio Rank

VMD
VMD Risk / Return Rank: 9090
Overall Rank
VMD Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VMD Sortino Ratio Rank: 8686
Sortino Ratio Rank
VMD Omega Ratio Rank: 8888
Omega Ratio Rank
VMD Calmar Ratio Rank: 9494
Calmar Ratio Rank
VMD Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMOS vs. VMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ChipMOS TECHNOLOGIES INC. (IMOS) and Viemed Healthcare Inc (VMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IMOSVMDDifference
Sharpe ratioReturn per unit of total volatility

+2.36

Sortino ratioReturn per unit of downside risk

+1.83

Omega ratioGain probability vs. loss probability

1.51

1.34

+0.17

Calmar ratioReturn relative to maximum drawdown

12.35

4.84

+7.51

Martin ratioReturn relative to average drawdown

28.82

12.04

+16.78

IMOS vs. VMD - Sharpe Ratio Comparison

The current IMOS Sharpe Ratio is 4.36, which is higher than the VMD Sharpe Ratio of 2.00. The chart below compares the historical Sharpe Ratios of IMOS and VMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IMOS vs. VMD - Drawdown Comparison

The maximum IMOS drawdown since its inception was -98.76%, which is greater than VMD's maximum drawdown of -69.35%. Use the drawdown chart below to compare losses from any high point for IMOS and VMD.


Loading charts...

Drawdown Indicators


IMOSVMDDifference

Max Drawdown

Largest peak-to-trough decline

-98.76%

-69.35%

-29.41%

Max Drawdown (1Y)

Largest decline over 1 year

-25.39%

-15.86%

-9.53%

Max Drawdown (3Y)

Largest decline over 3 years

-55.46%

-40.64%

-14.82%

Max Drawdown (5Y)

Largest decline over 5 years

-62.26%

-49.62%

-12.64%

Max Drawdown (10Y)

Largest decline over 10 years

-62.26%

Current Drawdown

Current decline from peak

0.00%

0.00%

0.00%

Average Drawdown

Average peak-to-trough decline

-60.31%

-29.22%

-31.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.97%

6.62%

+4.35%

Volatility

IMOS vs. VMD - Volatility Comparison

ChipMOS TECHNOLOGIES INC. (IMOS) has a higher volatility of 32.11% compared to Viemed Healthcare Inc (VMD) at 7.18%. This indicates that IMOS's price experiences larger fluctuations and is considered to be riskier than VMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IMOSVMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

32.11%

7.18%

+24.93%

Volatility (6M)

Calculated over the trailing 6-month period

59.95%

29.60%

+30.35%

Volatility (1Y)

Calculated over the trailing 1-year period

71.94%

38.33%

+33.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.36%

40.95%

+3.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.12%

57.60%

-17.48%

Dividends

IMOS vs. VMD - Dividend Comparison

IMOS's dividend yield for the trailing twelve months is around 1.03%, while VMD has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
IMOS
ChipMOS TECHNOLOGIES INC.
1.03%2.77%5.90%5.52%13.62%4.46%3.84%2.61%0.80%3.49%7.28%0.71%
VMD
Viemed Healthcare Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

IMOS vs. VMD - Financials Comparison

This section allows you to compare key financial metrics between ChipMOS TECHNOLOGIES INC. and Viemed Healthcare Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
219.23M
75.41M
(IMOS) Total Revenue
(VMD) Total Revenue
Please note, different currencies. IMOS values in TWD, VMD values in USD

IMOS vs. VMD - Profitability Comparison

The chart below illustrates the profitability comparison between ChipMOS TECHNOLOGIES INC. and Viemed Healthcare Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
13.8%
56.8%
Portfolio components
IMOS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported a gross profit of 30.20M and revenue of 219.23M. Therefore, the gross margin over that period was 13.8%.

VMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported a gross profit of 42.83M and revenue of 75.41M. Therefore, the gross margin over that period was 56.8%.

IMOS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported an operating income of 15.92M and revenue of 219.23M, resulting in an operating margin of 7.3%.

VMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported an operating income of 4.30M and revenue of 75.41M, resulting in an operating margin of 5.7%.

IMOS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, ChipMOS TECHNOLOGIES INC. reported a net income of 15.96M and revenue of 219.23M, resulting in a net margin of 7.3%.

VMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Viemed Healthcare Inc reported a net income of 2.58M and revenue of 75.41M, resulting in a net margin of 3.4%.


Frequently Asked Questions


IMOS and VMD have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IMOS has higher volatility (32.11%) compared to VMD (7.18%). In terms of maximum drawdown, IMOS dropped -98.76% vs VMD's -69.35%.

IMOS currently has the higher Sharpe Ratio (4.36 vs 2.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IMOS and VMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer